Ditchcarbon
  • Customers
  1. Organizations
  2. ANI Pharmaceuticals, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

ANI Pharmaceuticals, Inc.

Company website

ANI Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded prescription medications. With a focus on complex formulations, ANI Pharmaceuticals serves a diverse range of therapeutic areas, including pain management, oncology, and anti-infectives. The company’s commitment to innovation is evident in its extensive portfolio of products, which includes unique formulations that address unmet medical needs. ANI Pharmaceuticals has achieved significant milestones, including strategic acquisitions that have expanded its operational footprint across major regions in the US. With a strong market position and a dedication to quality, ANI Pharmaceuticals continues to make a meaningful impact in the healthcare landscape.

DitchCarbon Score

How does ANI Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

ANI Pharmaceuticals, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

ANI Pharmaceuticals, Inc.'s reported carbon emissions

ANI Pharmaceuticals, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments towards reducing its carbon footprint at this time. As there are no emissions data or reduction initiatives reported, ANI Pharmaceuticals, Inc. appears to be in the early stages of addressing climate-related issues within its operations. The absence of specific targets or commitments may reflect a broader trend in the pharmaceutical industry, where companies are increasingly being called upon to enhance transparency and take action on climate change. In summary, ANI Pharmaceuticals, Inc. has not yet disclosed any carbon emissions data or climate commitments, indicating a potential area for future development in sustainability practices.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ANI Pharmaceuticals, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ANI Pharmaceuticals, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ANI Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lupin Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Chengdu Kanghong Pharmaceutical Group Co., Ltd

CN
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Collegium Pharmaceutical, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Phastar

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Pacira BioSciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Supernus Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250804.4
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy